Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABLE Trial
ISRCTN16279802Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 2 trial of afatinib, sponsored by University of Leeds. Started Sep 2013; status: completed.
02
Drugs
afatinib
Beyond the preview
Go deeper on ISRCTN16279802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16279802.